Establishing Mechanical Thrombectomy at a Limited-volume Stroke Center - Effects on Patient Morbidity and Mortality

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-100
SponsorSorlandet Hospital HF

About this trial

The regional health authorities of South-East Norway has commissioned Sørlandet Hospital (SSHF), Norway to establish mechanical thrombectomy in large-vessel occlusion stroke. SSHF is a limited volume stroke center, and introduction of thrombectomy may impose quality challenges. Therefore the implementation will be guided by a simulation based quality assurance program. In this study, we will monitor timelines, technical and clinical outcomes, including adverse events.

Eligibility criteria

Qualifiers

Adult patients

Large vessel occlusion stroke

Disqualifiers

Intracranial hemorrhage, tumor, aneurism or vascular malformation i the stroke area

More than 24 hours after stroke onset

Trial design

Treatments tested in this trial

  • Simulation based quality program

Treatment groups

300 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Sorlandet Hospital HF

Lead sponsor

South-Eastern Norway Regional Health Authority

Collaborator

Helse Stavanger HF

Collaborator

University of Stavanger

Collaborator